Try digitalPLUS for 10 days for only $0.99
The Baltimore Sun

8th from bottom: Hospira, down 45.47%

Takeover talk is swirling around the Lake Forest drugmaker as the Abbott Laboratories spinoff works through regulatory concerns.
Loading
27°